Citations

Mayo Clinic

Showing 10 of 108453 citations.

471 | LONGITUDINAL scRNA‐seq CASE STUDY IDENTIFIES THREE STABLE AND DISTINCT B‐CELL SUBTYPES IN SERIAL SAMPLES OF A DIFFUSE B‐CELL LYMPHOMA FROM A SINGLE DOG
Treeful, Amy E. , Macchietto, Marissa , Reid, Kelly, Seelig, Davis , Demos-Davies, Kimberly , Büettner, Manuela , Pracht, Sara, Yung, C., Luethcke, R., Ditcovsky, R., Kuzmik, Alana R., Borgatti, A., Henson, Morgan , Feiock, Caitlin, Sarver, A. L., Walker, G., Winter, A., Buettner, M., Burt, L., Penza, V., Adams, R., Vallera, Daniel A. , Henson, M., Modiano, Jaime F. , Naik, S., Sarver, A. L.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_471 Get It

441 | GOLCADOMIDE, A CEREBLON E3 LIGASE MODULATOR (CELMoD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED PHASE 1/2 RESULTS
Cordoba, R., Perini, Guilherme Fleury , Jørgensen, Judit , Bijou, Fontanet , Munoz, J., Kim, W. S., Rao, P. , Moucheron, Bérengère de, Yang, Gang , Carrancio, Soraya , Sudhindra, Akshay, Voetsch, Jessica, Cordoba, R., Chavez, Julio C , Nastoupil, Loretta J. , Bories, Pierre , Zinzani, Pier Luigi , Munoz, J., Carpio, Cecilia del Carmen , Costa, Alfredo Cardoso , Pourdehnad, Michael , Michot, Jean‐Marie

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_441 Get It

487 | MicroRNAs TARGET TUMOR SUPPRESSOR GRK2 IN MALT1‐DEPENDENT DIFFUSE LARGE B‐CELL LYMPHOMA
Cheng, Jing , Smyers, M., Trotta, M., Chandran, Uma , Xia, Min , McAllister‐Lucas, Linda M. , Carleton, Neil M. , Maurer, Lisa M. , Melnick, Ari , Lucas, Peter C.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_487 Get It

505 | EMERGING EVIDENCE OF MICROBIOTA COMPOSITION LINKED TO ADVERSE EVENTS DURING IMMUNOTHERAPY IN DOGS WITH LYMPHOMA
Treeful, Amy E. , Dietz, Michael, Reid, Kenneth , Büettner, Manuela , Chehadeh, Andrea, Pracht, Sara, Luethcke, R., Yung, C., Demos-Davies, Kimberly , Seelig, Davis , Feiock, Caitlin, Henson, Morgan , Borgatti, Antonella , Shruthi, N, Dietz, M., Reid, K., Buettner, M., Winter, A., Penza, V., Adams, R., Vallera, Daniel A. , Henson, M., Staley, Christopher , Modiano, Jaime F. , Shruthi, N.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_505 Get It

450 | 5‐5‐5 ABRT (ADAPTIVE BRIDGING RADIATION THERAPY)—ARTIFICIAL INTELLIGENCE ENTERS THE CAR (‐T) IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS
Ababneh, H., Ng, Andrea K. , Walburn, Tyler , Johnson, P. C., Bredtfeld, Jeremy, Leeman, Jonathan E. , Barnes, J. , Takvorian, Ronald W., Frigault, M., Patel, Chirayu G. , Wan, Juefeng , Zhu, Lin L. , Bobić, Mislav , Soumerai, Jacob D. , Abramson, J., Pursley, J.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70094_450 Get It

478 | SINGLE‐CELL RNA SEQUENCING UNCOVERS AP‐1 TRANSCRIPTIONAL UPREGULATION IN CANINE DIFFUSE LARGE B‐CELL LYMPHOMA
Sarver, Aaron L. , Treeful, Amy E. , Macchietto, Marissa , Reid, Kenneth , Seelig, Davis , Demos-Davies, Kimberly , Büettner, Manuela , Pracht, Sara, Yung, C., Luethcke, R., Borgatti, Antonella , Henson, Morgan , Feiock, Caitlin, Naik, Swati , Callaghan, C., Walker, G., Lloréns, J., Reid, K., Winter, A., Buettner, M., Burt, L., Penza, V., Adams, Ralf H. , Vallera, Daniel A. , Henson, M., Naik, S., Modiano, Jaime F.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_478 Get It

557 | EVALUATING UPTAKE OF TARGETED AGENTS BY RACE/ETHNICITY IN PATIENTS RECEIVING FIRST‐LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA
Kittai, Adam S. , Hampel, Paul J. , Fu, Qiang , Sun, Steven , Beuge, Derrick van, Maglinte, Gregory A. , Rhodes, Joanna , Wang, X., Seymour, Erlene Kuizon , Barrientos, Jacqueline C.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_557 Get It

549 | PROSPECTIVE PATIENT PREFERENCE STUDY FOR CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT ATTRIBUTES IMPACTING PATIENT SHARED‐DECISION MAKING
Challagulla, Swetha, Pilon, Dominic , Meng, Yan , Díaz, Lilián , Ailawadhi, Sikander , Totev, Todor , Meng, Y., Diaz, L., Chen, Zhiguo , Yang, Kehu

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_549 Get It

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
Ganguly, Abhrajit , Carter, Cynthia, Negron, Aristides Rivera, Moreira, Alvaro , Richardson, Arlan, Zhong, Hua , Walters, Matthew S. , Rogers, Lynette Kay , Prakash, Y. S. , Tipple, Trent E.

No container title available | June 15, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.06.15.659571 | PMID 40661380 Get It

ABSTRACT Premature infants often require supplemental oxygen therapy, however, exposure to supraphysiological oxygen (hyperoxia) can disrupt normal lung development and contribute to bronchopulmonary dysplasia (BPD). Mitochondrial dysfunction is increasingly recognized as a contributor to hyperoxia-induced BPD. However, the effects of hyperoxia on mitochondrial function and mucociliary differentiation in the developing upper airway epithelium remain poorly understood. This study tested the hypothesis that hyperoxia impairs neonatal airway mucociliary differentiation by disrupting mitochondrial bioenergetic function. Neonatal tracheal airway epithelial cells (nTAECs) from term infants (n=5) were cultured in a 3D air-liquid interface (ALI) model and exposed to 60% O₂ during the mid-phase of differentiation (ALI day 7-14). Cellular phenotype was assessed using immunofluorescence staining and gene expression analyses. Mitochondrial function was evaluated through Seahorse metabolic flux analysis, and global protein changes were characterized by quantitative proteomics. Hyperoxia exposure significantly impaired terminal epithelial differentiation, characterized by reductions in ciliated and goblet cells. Seahorse assay revealed a decrease in baseline oxygen consumption and mitochondrial ATP production, accompanied by a compensatory increase in glycolytic ATP production. Quantitative proteomics identified disruption of mitochondrial Complex I as a central feature of the hyperoxic response. Downstream proteomic pathway analyses further confirmed the metabolic shift from mitochondrial to glycolytic ATP production and demonstrated altered epithelial differentiation pathways, including NOTCH and TGF-β signaling. These findings reveal that moderate hyperoxia impairs mitochondrial bioenergetics and alters metabolic programming, leading to disrupted mucociliary differentiation. Future in vivo studies should evaluate mitochondrial oxidative fitness as a therapeutic target in neonatal lung disease. NEW & NOTEWORTHY We report that moderate hyperoxia during a critical window of mucociliary differentiation disrupts terminal maturation in neonatal airway epithelial cells cultured in a 3D model. Hyperoxia induced mitochondrial bioenergetic dysfunction and metabolic reprogramming, with proteomic analysis identifying Complex I disruption as a key driver of impaired differentiation. Overall, these findings reveal a previously underrecognized link between mitochondrial bioenergetics and airway epithelial development, positioning metabolic dysfunction as an early trigger of hyperoxia-induced neonatal airway injury.